Crossmark

The question of alteplase dose for stroke is not resolved

Crossref DOI link: https://doi.org/10.1038/nrneurol.2016.90

Published Online: 2016-06-24

Published Print: 2016-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aoki, Junya

Kimura, Kazumi
License Information

Text and Data Mining valid from 2016-06-24
More Information

Article History

First Online: 24 June 2016

Competing interests

: J.A. has received lecture fees and speaker's fees from Daiichi Sankyo and Tanabe Mitsubishi. K.K. has received lecture fees and speaker's fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Otsuka, Pfizer and Tanabe Mitsubishi.